Skip to content

The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection

Evaluation of the Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Mycobacterium Tuberculosis Infection in Korean Patients With Rheumatic Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01685905
Enrollment
2000
Registered
2012-09-14
Start date
2012-04-30
Completion date
2013-09-30
Last updated
2012-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis, Rheumatic Disease, Rheumatoid Arthritis, Tuberculosis

Keywords

rheumatic disease, latent tuberculosis

Brief summary

The purposes of this study 1. to compare the positivity of tuberculin skin test(TST) and QuantiFERON-TB Gold (QFT-G), and determine the level of agreement between two tests in patients with rheumatic diseases 2. to evaluate the difference in the occurrence of active TB in patients who receive both QFT-G and TST compared with those who receive only TST for detecting of Latent tuberculosis infection(LTBI) who are candidates of TNF inhibitors.

Detailed description

Study Assessment 1. The positive rates of QFT-G and TST as a screening test for LTBI * The positive rates of QFT-G and TST will be analyzed * Additional analysis will be performed according to the type of disease 2. The agreement between QFT-G and TST as a screening test for LTBI * The agreement between QFT-G and TST will be analyzed for patients with rheumatic diseases who examined both QFT-G and TST * Additional analysis will be performed according to the type of disease 3. The correlation of the occurrence of active TB and two tests (QFT-G and TST) * The analysis of the correlation of the occurrence of active TB and two tests will be conducted for patients who have experienced anti-TNF agents 3-1. The occurrence of active TB in accordance with results of TST 3-2. The occurrence of active TB in accordance with results of QFT-G 3-3. The difference in the occurrence of active TB in patients performed both QFT-G and TST compared with those performed only TST for detecting of LTBI who are candidates of TNF inhibitors (pilot study).

Interventions

None listed

Sponsors

Bristol-Myers Squibb
CollaboratorINDUSTRY
Hanyang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with rheumatic diseases who examined TST or QFT-G in Hanyang university hospital from 2004 to 2010

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frame
The agreement between QuantiFERON-TB Gold(QFT-G) and tuberculin skin test(TST) as a screening test for latent tuberculosis infection(LTBI)one year

Secondary

MeasureTime frame
The correlation of the occurrence of active Tuberculosis and two tests (QuantiFERON-TB Gold (QFT-G) and tuberculosis skin test(TST))one year

Countries

South Korea

Contacts

Primary ContactSang-cheol Bae, director
scbae@hanyang.ac.kr82-2-2290-8260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026